OverviewChartNewsTraderScreen

Morgan Stanley Call 42 FRE 20.09..../  DE000ME10YX3  /

Stuttgart
14/05/2024  17:30:14 Chg.0.000 Bid17:37:45 Ask17:37:45 Underlying Strike price Expiration date Option type
0.010EUR 0.00% 0.010
Bid Size: 15,000		 0.040
Ask Size: 15,000		 FRESENIUS SE+CO.KGAA... 42.00 - 20/09/2024 Call
GlobeNewswire 23/04 Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire 04/01 Sigyn Therapeutics Releases Letter to Shareholders
GlobeNewswire 09/11/2023 CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
GlobeNewswire 04/09/2023 CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire 31/08/2023 CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
TeleTrader 11/07/2023 Europe opens mostly higher with data, NATO in focus
TeleTrader 23/12/2022 Europe closes mixed ahead of Christmas
TeleTrader 31/10/2022 Europe closes mostly higher, inflation hits new record
GlobeNewswire 25/02/2022 Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodia...
TeleTrader 22/02/2022 Europe closes mostly lower amid Ukraine worries
GlobeNewswire 03/02/2022 RAYALDEE® Launched in Germany by OPKO Health’s Licensee, VFMCRP
TeleTrader 17/01/2022 Europe opens higher amid the Forum, COVID data
GlobeNewswire 05/01/2022 Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China)
GlobeNewswire 31/12/2021 CIO Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its 15th Y...
GlobeNewswire 09/12/2021 Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in Cardiac Surge...
GlobeNewswire 22/11/2021 Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
GlobeNewswire 22/11/2021 Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
GlobeNewswire 12/11/2021 Humacyte Reports Third Quarter 2021 Financial Results and Provides Business Highlights
GlobeNewswire 08/11/2021 Cara Therapeutics Reports Third Quarter 2021 Financial Results
GlobeNewswire 27/10/2021 CIO Leadership: Exemplifying Authentic Leadership and Leveraging Personal Branding to Act as a Globa...
GlobeNewswire 26/10/2021 Angion and Vifor Pharma Report Topline Results from Phase 3 Trial of ANG-3777 in Kidney Transplant P...
GlobeNewswire 15/09/2021 Travere Therapeutics and Vifor Pharma Announce Licensing Agreement for the Commercialization of Spar...
GlobeNewswire 26/08/2021 Humacyte Announces Successful Closing of Business Combination with Alpha Healthcare Acquisition Corp...
GlobeNewswire 23/08/2021 Cara Therapeutics and Vifor Pharma announce U.S. FDA approval of KORSUVA™ (difelikefalin) injection ...
TeleTrader 30/07/2021 Europe closes lower after data, earnings